Arcus Biosciences
RCUS
RCUS
185 hedge funds and large institutions have $1.25B invested in Arcus Biosciences in 2024 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 61 increasing their positions, 67 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1% less funds holding
Funds holding: 186 → 185 (-1)
9% less repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 67
Holders
185
Holding in Top 10
2
Calls
$5.08M
Puts
$2.08M
Top Buyers
| 1 | +$11.9M | |
| 2 | +$10.1M | |
| 3 | +$8.8M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$6.93M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$6.6M |
Top Sellers
| 1 | -$18.3M | |
| 2 | -$8.02M | |
| 3 | -$6.56M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.18M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$5.44M |